Page 27 - Multiple Sclerosis Ms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The wearable EksoNR robotic exoskeleton is the first FDA-cleared exoskeleton for use in the rehabilitation of patients with multiple sclerosis.

In a new study of more than 600 patients with multiple sclerosis, about 1 in 25 faced a potentially severe drug-drug interaction, with more having at least one potentially risky interaction.

The novel anti-CD20 monoclonal antibody ublituximab showed greater improvement vs terifulnomide in stabilizing disease progression in relapsing multiple sclerosis in two phase 3 trials.

The investigational evobrutinib, an Bruton's tyrosine kinase inhibitor, showed favorable safety and efficacy in the longest trial to date of a drug in this class in patients with multiple sclerosis.

General neurologists fall short in their knowledge of key multiple sclerosis diagnostic criteria standards compared with MS experts, new findings show, which may be detrimental to patient management.